Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfatc2
|
ENSMUSG00000027544.10 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_168601445_168601678 | Nfatc2 | 71 | 0.978119 | 0.88 | 1.0e-18 | Click! |
chr2_168601687_168602100 | Nfatc2 | 236 | 0.940803 | 0.87 | 5.6e-18 | Click! |
chr2_168601214_168601434 | Nfatc2 | 308 | 0.914619 | 0.83 | 5.9e-15 | Click! |
chr2_168602177_168602328 | Nfatc2 | 595 | 0.778267 | 0.78 | 2.8e-12 | Click! |
chr2_168589145_168589332 | Nfatc2 | 953 | 0.627287 | 0.73 | 3.8e-10 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrY_90739614_90740540 | 46.91 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr7_73917720_73918558 | 44.43 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr16_44632721_44633371 | 43.15 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr3_139885937_139886924 | 33.11 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr10_70484969_70485278 | 31.70 |
Gm29783 |
predicted gene, 29783 |
20125 |
0.19 |
chr16_56096413_56096857 | 29.69 |
Gm18723 |
predicted gene, 18723 |
204 |
0.91 |
chr10_118102987_118104071 | 29.49 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr11_32383714_32384390 | 29.47 |
Sh3pxd2b |
SH3 and PX domains 2B |
36212 |
0.13 |
chr19_36534720_36535517 | 26.03 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr4_82705266_82705715 | 25.85 |
Nfib |
nuclear factor I/B |
260 |
0.93 |
chr11_30472050_30472456 | 25.70 |
4930505A04Rik |
RIKEN cDNA 4930505A04 gene |
426 |
0.87 |
chr10_56892903_56893581 | 24.49 |
Gm48053 |
predicted gene, 48053 |
21523 |
0.23 |
chr13_84571404_84571594 | 23.61 |
Gm26913 |
predicted gene, 26913 |
119442 |
0.06 |
chr5_42067440_42068088 | 23.16 |
Gm16223 |
predicted gene 16223 |
196 |
0.97 |
chr9_108587464_108588439 | 23.13 |
Gm49209 |
predicted gene, 49209 |
899 |
0.26 |
chr5_103911497_103911895 | 22.67 |
Klhl8 |
kelch-like 8 |
437 |
0.79 |
chr13_51418115_51418579 | 22.62 |
Gm32834 |
predicted gene, 32834 |
298 |
0.91 |
chr11_113144264_113144583 | 22.31 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
28654 |
0.23 |
chr2_17730264_17731671 | 22.29 |
Nebl |
nebulette |
76 |
0.98 |
chr13_72419489_72419940 | 21.98 |
Rpl9-ps4 |
ribosomal protein L9, pseudogene 4 |
35626 |
0.14 |
chr13_40606396_40606745 | 21.51 |
Gm47039 |
predicted gene, 47039 |
91 |
0.97 |
chr1_94503928_94504626 | 21.27 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr2_17839635_17839891 | 21.07 |
Gm13323 |
predicted gene 13323 |
41779 |
0.17 |
chr12_61522794_61523620 | 21.03 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
40 |
0.97 |
chr2_122708149_122708787 | 21.02 |
4930417H01Rik |
RIKEN cDNA 4930417H01 gene |
425 |
0.78 |
chr13_90152829_90153210 | 21.02 |
Gm37727 |
predicted gene, 37727 |
4135 |
0.23 |
chrX_143932561_143932819 | 20.60 |
Dcx |
doublecortin |
360 |
0.92 |
chr6_39242951_39243777 | 20.29 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr7_45460493_45461322 | 20.18 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr14_93067075_93067302 | 20.15 |
Gm23509 |
predicted gene, 23509 |
71001 |
0.12 |
chr6_39871251_39871962 | 19.19 |
Tmem178b |
transmembrane protein 178B |
145 |
0.75 |
chr13_8333561_8334203 | 19.07 |
Gm48260 |
predicted gene, 48260 |
34739 |
0.14 |
chr14_19977078_19977720 | 18.96 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
150 |
0.96 |
chr15_4375774_4376213 | 18.94 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
489 |
0.88 |
chr4_3051990_3053232 | 18.94 |
Gm27878 |
predicted gene, 27878 |
792 |
0.7 |
chr1_137373621_137374166 | 18.93 |
Gm23534 |
predicted gene, 23534 |
6646 |
0.26 |
chr18_15150000_15150584 | 18.91 |
Kctd1 |
potassium channel tetramerisation domain containing 1 |
1154 |
0.54 |
chr10_78747019_78747870 | 18.88 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr1_81520769_81521201 | 18.73 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr11_54754283_54754711 | 18.71 |
Cdc42se2 |
CDC42 small effector 2 |
5842 |
0.15 |
chr15_67898912_67899432 | 18.71 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr16_85054134_85054285 | 18.64 |
Gm49227 |
predicted gene, 49227 |
25902 |
0.15 |
chr10_18020913_18021146 | 18.60 |
Abracl |
ABRA C-terminal like |
1849 |
0.33 |
chr4_22835787_22836371 | 18.59 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr1_82292424_82293208 | 18.56 |
Irs1 |
insulin receptor substrate 1 |
1400 |
0.42 |
chr7_62231071_62231594 | 18.52 |
Gm9801 |
predicted gene 9801 |
21853 |
0.21 |
chr15_25754647_25755340 | 18.43 |
Myo10 |
myosin X |
2014 |
0.38 |
chr13_83727942_83728228 | 18.28 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
21 |
0.96 |
chr5_133385739_133386398 | 18.25 |
Gm42625 |
predicted gene 42625 |
57274 |
0.15 |
chr9_41157940_41158229 | 18.13 |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
22 |
0.96 |
chr2_25240744_25241709 | 18.11 |
Cysrt1 |
cysteine rich tail 1 |
1226 |
0.15 |
chr6_29835800_29836301 | 18.02 |
Ahcyl2 |
S-adenosylhomocysteine hydrolase-like 2 |
17710 |
0.17 |
chr17_55969161_55969943 | 17.96 |
Shd |
src homology 2 domain-containing transforming protein D |
915 |
0.34 |
chr9_18473066_18474201 | 17.82 |
Zfp558 |
zinc finger protein 558 |
74 |
0.95 |
chr6_28864735_28865082 | 17.79 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
15135 |
0.19 |
chr19_15801412_15801721 | 17.76 |
Gm50348 |
predicted gene, 50348 |
1492 |
0.52 |
chr7_89046648_89046859 | 17.50 |
Tmem135 |
transmembrane protein 135 |
98744 |
0.08 |
chr18_8054510_8054913 | 17.43 |
Gm4833 |
predicted gene 4833 |
3508 |
0.33 |
chr2_152741456_152742233 | 17.14 |
Gm14162 |
predicted gene 14162 |
3863 |
0.13 |
chr2_70210522_70210673 | 17.00 |
Myo3b |
myosin IIIB |
114299 |
0.06 |
chr13_113917716_113918082 | 16.84 |
Arl15 |
ADP-ribosylation factor-like 15 |
123277 |
0.05 |
chr16_77417976_77418151 | 16.76 |
Gm38071 |
predicted gene, 38071 |
1439 |
0.27 |
chr18_8871292_8871740 | 16.73 |
Gm37148 |
predicted gene, 37148 |
56719 |
0.14 |
chr4_32923442_32923826 | 16.72 |
Ankrd6 |
ankyrin repeat domain 6 |
129 |
0.96 |
chr3_11261156_11261347 | 16.68 |
Gm22547 |
predicted gene, 22547 |
106914 |
0.08 |
chr1_88254702_88255947 | 16.42 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr7_77812001_77812153 | 16.39 |
Gm23239 |
predicted gene, 23239 |
98243 |
0.09 |
chr4_63228909_63229371 | 16.38 |
Col27a1 |
collagen, type XXVII, alpha 1 |
5146 |
0.19 |
chr2_49603087_49603271 | 16.31 |
Kif5c |
kinesin family member 5C |
16119 |
0.24 |
chr15_78876224_78876768 | 16.28 |
Gga1 |
golgi associated, gamma adaptin ear containing, ARF binding protein 1 |
694 |
0.44 |
chr7_19094759_19096427 | 16.27 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr5_119082830_119083079 | 16.18 |
1700081H04Rik |
RIKEN cDNA 1700081H04 gene |
25280 |
0.21 |
chr3_6106672_6106878 | 16.15 |
Gm17934 |
predicted gene, 17934 |
31469 |
0.2 |
chr10_80225959_80227288 | 16.13 |
Pwwp3a |
PWWP domain containing 3A, DNA repair factor |
32 |
0.94 |
chr4_13779122_13779296 | 16.13 |
Runx1t1 |
RUNX1 translocation partner 1 |
5573 |
0.32 |
chr1_42703489_42704501 | 16.05 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr5_75070641_75071159 | 16.03 |
Gsx2 |
GS homeobox 2 |
4701 |
0.14 |
chr5_66543829_66544028 | 16.01 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
3029 |
0.2 |
chr12_12527352_12527675 | 16.01 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
134898 |
0.04 |
chr2_10374243_10374943 | 15.88 |
Gm13261 |
predicted gene 13261 |
552 |
0.39 |
chr15_57162413_57162847 | 15.80 |
Gm26178 |
predicted gene, 26178 |
76483 |
0.11 |
chr8_12947304_12948554 | 15.80 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr10_70952281_70952535 | 15.79 |
Bicc1 |
BicC family RNA binding protein 1 |
3919 |
0.2 |
chr6_55791826_55792546 | 15.77 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr6_55452389_55452881 | 15.73 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
458 |
0.84 |
chr10_120377353_120377777 | 15.69 |
9230105E05Rik |
RIKEN cDNA 9230105E05 gene |
11958 |
0.16 |
chr6_13836676_13836883 | 15.68 |
Gpr85 |
G protein-coupled receptor 85 |
462 |
0.83 |
chr2_105674521_105675719 | 15.67 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr3_50983938_50984284 | 15.65 |
Gm37209 |
predicted gene, 37209 |
5300 |
0.24 |
chr12_61523789_61524084 | 15.63 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
12 |
0.97 |
chr16_33605736_33606716 | 15.59 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr15_56078123_56078460 | 15.58 |
Gm49212 |
predicted gene, 49212 |
28459 |
0.19 |
chr12_3364588_3366025 | 15.51 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr5_37716863_37717819 | 15.46 |
Stk32b |
serine/threonine kinase 32B |
170 |
0.96 |
chr6_40431416_40431824 | 15.30 |
Dennd11 |
DENN domain containing 11 |
212 |
0.91 |
chr3_83286982_83287162 | 15.27 |
Gm38096 |
predicted gene, 38096 |
116330 |
0.06 |
chr9_83316530_83316798 | 15.27 |
Gm46123 |
predicted gene, 46123 |
29495 |
0.16 |
chr5_111057192_111057523 | 15.26 |
Gm42780 |
predicted gene 42780 |
28805 |
0.14 |
chr5_4834822_4835395 | 15.21 |
Gm43113 |
predicted gene 43113 |
7015 |
0.13 |
chr16_96200279_96201093 | 15.20 |
Sh3bgr |
SH3-binding domain glutamic acid-rich protein |
15 |
0.97 |
chr17_9725703_9726083 | 15.19 |
Gm34684 |
predicted gene, 34684 |
460 |
0.85 |
chr2_110210346_110211082 | 15.17 |
Gm13937 |
predicted gene 13937 |
549 |
0.76 |
chr13_84344282_84344641 | 15.12 |
Gm26927 |
predicted gene, 26927 |
4348 |
0.26 |
chr5_18359524_18360084 | 15.10 |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 |
551 |
0.82 |
chr2_65847807_65847994 | 15.08 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
2045 |
0.35 |
chr16_28752897_28753619 | 15.04 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr4_39344820_39345025 | 15.03 |
Gm23607 |
predicted gene, 23607 |
49459 |
0.14 |
chr11_31999868_32000096 | 14.98 |
Nsg2 |
neuron specific gene family member 2 |
481 |
0.83 |
chr12_29368602_29368857 | 14.98 |
Gm6989 |
predicted gene 6989 |
51161 |
0.17 |
chr15_40114597_40115428 | 14.97 |
9330182O14Rik |
RIKEN cDNA 9330182O14 gene |
19353 |
0.17 |
chr18_35214941_35215148 | 14.97 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
20 |
0.56 |
chr16_15723894_15724278 | 14.96 |
Gm49511 |
predicted gene, 49511 |
26837 |
0.18 |
chr10_70640141_70640690 | 14.95 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
11510 |
0.24 |
chr10_81364518_81366962 | 14.94 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr10_106609605_106610022 | 14.92 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr16_77643967_77644261 | 14.87 |
Mir125b-2 |
microRNA 125b-2 |
2159 |
0.17 |
chr9_41579727_41580423 | 14.86 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
97 |
0.93 |
chr3_94477580_94477909 | 14.86 |
Celf3 |
CUGBP, Elav-like family member 3 |
551 |
0.54 |
chr6_107530774_107531343 | 14.81 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
1290 |
0.51 |
chr3_159885217_159885703 | 14.81 |
Gm43307 |
predicted gene 43307 |
9614 |
0.23 |
chr8_14306720_14307413 | 14.80 |
Gm26184 |
predicted gene, 26184 |
33755 |
0.17 |
chr2_51066696_51066895 | 14.79 |
Rnd3 |
Rho family GTPase 3 |
82299 |
0.1 |
chr4_20777672_20778960 | 14.77 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr1_144006670_144006898 | 14.77 |
Rgs2 |
regulator of G-protein signaling 2 |
2623 |
0.4 |
chr1_12718111_12718737 | 14.69 |
Sulf1 |
sulfatase 1 |
35 |
0.98 |
chr4_82532408_82532766 | 14.68 |
Gm11266 |
predicted gene 11266 |
24571 |
0.17 |
chr1_119033632_119034415 | 14.63 |
Gli2 |
GLI-Kruppel family member GLI2 |
19316 |
0.19 |
chr15_27224557_27224708 | 14.61 |
Gm19111 |
predicted gene, 19111 |
143307 |
0.04 |
chr2_21917593_21918874 | 14.60 |
Gm24886 |
predicted gene, 24886 |
123178 |
0.06 |
chr8_99416428_99416802 | 14.57 |
A330008L17Rik |
RIKEN cDNA A330008L17 gene |
27 |
0.64 |
chr10_126641848_126642305 | 14.57 |
Gm40797 |
predicted gene, 40797 |
21922 |
0.18 |
chr3_159851998_159852454 | 14.51 |
Wls |
wntless WNT ligand secretion mediator |
3775 |
0.28 |
chr6_77050888_77051068 | 14.48 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
92965 |
0.09 |
chr1_85598209_85599024 | 14.43 |
Sp110 |
Sp110 nuclear body protein |
133 |
0.84 |
chr1_51697455_51697651 | 14.39 |
Gm28055 |
predicted gene 28055 |
347 |
0.91 |
chr18_14844486_14844862 | 14.36 |
Gm21055 |
predicted gene, 21055 |
14006 |
0.21 |
chr18_34006863_34007553 | 14.33 |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4a |
242 |
0.92 |
chr4_81999671_82000143 | 14.33 |
Gm22402 |
predicted gene, 22402 |
61314 |
0.1 |
chr2_115483419_115483780 | 14.30 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
28602 |
0.21 |
chr13_69481997_69482222 | 14.28 |
Gm48676 |
predicted gene, 48676 |
31891 |
0.13 |
chr5_135544822_135545976 | 14.27 |
Hip1 |
huntingtin interacting protein 1 |
279 |
0.87 |
chr14_22738699_22738908 | 14.26 |
Gm7473 |
predicted gene 7473 |
36441 |
0.22 |
chr3_34649198_34650117 | 14.26 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr1_6733683_6734408 | 14.23 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr3_27862930_27863950 | 14.23 |
Gm26040 |
predicted gene, 26040 |
4673 |
0.26 |
chr6_114968557_114970098 | 14.22 |
Vgll4 |
vestigial like family member 4 |
147 |
0.97 |
chr1_18058368_18058994 | 14.18 |
Gm28756 |
predicted gene 28756 |
109 |
0.82 |
chr11_32161571_32162227 | 14.15 |
Gm12109 |
predicted gene 12109 |
23106 |
0.12 |
chr4_116016940_116018214 | 14.14 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr4_33524476_33525134 | 14.14 |
Gm11935 |
predicted gene 11935 |
71916 |
0.1 |
chr4_97476586_97476891 | 14.12 |
Gm12696 |
predicted gene 12696 |
45594 |
0.18 |
chr13_110280472_110281172 | 14.08 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr19_32555436_32555731 | 14.06 |
Gm36419 |
predicted gene, 36419 |
12235 |
0.19 |
chr1_39902764_39903132 | 14.06 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
1718 |
0.42 |
chr10_38553365_38553786 | 14.04 |
Gm22911 |
predicted gene, 22911 |
61906 |
0.14 |
chr6_76977966_76978159 | 14.01 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
75174 |
0.12 |
chr8_79209341_79209626 | 14.01 |
Gm30329 |
predicted gene, 30329 |
16447 |
0.17 |
chr10_68558529_68558761 | 13.99 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
16749 |
0.22 |
chr17_52600562_52601051 | 13.98 |
Gm27217 |
predicted gene 27217 |
1854 |
0.34 |
chr1_42691969_42692512 | 13.98 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
853 |
0.48 |
chr17_55367602_55367789 | 13.95 |
Gm49921 |
predicted gene, 49921 |
21012 |
0.2 |
chr9_90041035_90041357 | 13.92 |
Gm17944 |
predicted gene, 17944 |
7953 |
0.18 |
chr3_16431457_16431615 | 13.91 |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein 3 |
248300 |
0.02 |
chr11_32157683_32158170 | 13.90 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr4_141312456_141313176 | 13.88 |
Epha2 |
Eph receptor A2 |
3922 |
0.13 |
chr14_116926469_116927236 | 13.87 |
Gpc6 |
glypican 6 |
916 |
0.75 |
chr13_52562127_52562509 | 13.86 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr18_57262231_57262735 | 13.83 |
Gm50200 |
predicted gene, 50200 |
52657 |
0.11 |
chr17_24736037_24737110 | 13.81 |
Msrb1 |
methionine sulfoxide reductase B1 |
69 |
0.91 |
chr3_37816924_37817412 | 13.77 |
Gm26404 |
predicted gene, 26404 |
14516 |
0.13 |
chr3_63413619_63413824 | 13.77 |
Gm34240 |
predicted gene, 34240 |
25530 |
0.19 |
chr13_15759168_15760299 | 13.75 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr9_62555521_62555672 | 13.72 |
Coro2b |
coronin, actin binding protein, 2B |
18552 |
0.21 |
chr10_81383963_81384933 | 13.64 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
11 |
0.48 |
chr9_36821327_36821662 | 13.64 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chr1_88668916_88669101 | 13.61 |
Gm29336 |
predicted gene 29336 |
12700 |
0.16 |
chr3_119946869_119947112 | 13.61 |
Gm18384 |
predicted gene, 18384 |
21741 |
0.24 |
chr2_94265618_94265929 | 13.60 |
Mir670hg |
MIR670 host gene (non-protein coding) |
855 |
0.53 |
chr10_13715016_13715199 | 13.59 |
Gm48773 |
predicted gene, 48773 |
87909 |
0.08 |
chr4_131244074_131244263 | 13.58 |
Gm25261 |
predicted gene, 25261 |
4891 |
0.33 |
chr10_38553865_38554067 | 13.54 |
Gm22911 |
predicted gene, 22911 |
61515 |
0.14 |
chr10_34904244_34904432 | 13.53 |
Gm8834 |
predicted gene 8834 |
6082 |
0.26 |
chr6_112809545_112809826 | 13.50 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr13_53205183_53205803 | 13.46 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
70165 |
0.11 |
chr6_16317881_16318284 | 13.45 |
Gm3148 |
predicted gene 3148 |
80455 |
0.1 |
chr18_4186646_4187021 | 13.44 |
Gm10557 |
predicted gene 10557 |
12105 |
0.2 |
chr5_39803670_39803850 | 13.44 |
Gm7816 |
predicted pseudogene 7816 |
5546 |
0.28 |
chrX_19904603_19905052 | 13.41 |
Gm5384 |
predicted gene 5384 |
11170 |
0.23 |
chr1_60936284_60936466 | 13.40 |
Gm11582 |
predicted gene 11582 |
12090 |
0.14 |
chr4_33923059_33923360 | 13.40 |
Cnr1 |
cannabinoid receptor 1 (brain) |
1384 |
0.54 |
chr12_45013262_45013696 | 13.39 |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
515 |
0.83 |
chr18_9216377_9216790 | 13.38 |
Fzd8 |
frizzled class receptor 8 |
4420 |
0.27 |
chr7_79519799_79520848 | 13.34 |
Gm37608 |
predicted gene, 37608 |
3441 |
0.11 |
chr9_118227897_118228048 | 13.32 |
Gm17399 |
predicted gene, 17399 |
77741 |
0.09 |
chr13_18947816_18948472 | 13.31 |
Amph |
amphiphysin |
61 |
0.97 |
chr14_79851388_79851627 | 13.30 |
Gm6999 |
predicted gene 6999 |
14795 |
0.16 |
chr4_65838866_65839193 | 13.21 |
Trim32 |
tripartite motif-containing 32 |
233780 |
0.02 |
chr7_70118154_70118466 | 13.20 |
Gm35325 |
predicted gene, 35325 |
89125 |
0.08 |
chr16_44579789_44580020 | 13.17 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
21007 |
0.18 |
chr2_22029338_22029851 | 13.16 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.1 | 69.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
14.9 | 44.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
14.7 | 44.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
13.6 | 54.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
12.6 | 50.4 | GO:0060486 | Clara cell differentiation(GO:0060486) |
11.1 | 33.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
9.7 | 29.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
8.8 | 35.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
8.7 | 8.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
8.2 | 49.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
8.2 | 57.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
8.1 | 24.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
7.9 | 31.8 | GO:0007412 | axon target recognition(GO:0007412) |
7.9 | 31.6 | GO:0001927 | exocyst assembly(GO:0001927) |
7.8 | 39.0 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
7.6 | 7.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
7.3 | 21.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
6.8 | 20.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
6.6 | 19.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
6.4 | 19.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
6.4 | 32.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
6.4 | 19.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
6.4 | 19.2 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
6.2 | 18.5 | GO:0030070 | insulin processing(GO:0030070) |
6.1 | 18.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
6.1 | 6.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
6.1 | 18.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
6.0 | 54.3 | GO:0071625 | vocalization behavior(GO:0071625) |
6.0 | 18.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
6.0 | 6.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
6.0 | 6.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
5.9 | 35.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
5.8 | 23.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
5.8 | 28.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.7 | 17.1 | GO:0021586 | pons maturation(GO:0021586) |
5.7 | 11.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
5.5 | 27.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
5.5 | 10.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
5.4 | 91.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
5.4 | 16.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
5.3 | 21.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
5.2 | 36.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
5.1 | 5.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
5.1 | 15.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
5.0 | 5.0 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
5.0 | 25.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
5.0 | 5.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
4.9 | 14.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
4.9 | 24.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
4.9 | 14.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
4.9 | 19.6 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
4.9 | 39.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.9 | 38.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
4.7 | 23.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
4.7 | 18.8 | GO:0030091 | protein repair(GO:0030091) |
4.7 | 14.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
4.7 | 18.6 | GO:0060437 | lung growth(GO:0060437) |
4.6 | 9.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
4.6 | 13.7 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
4.6 | 13.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
4.5 | 13.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
4.4 | 13.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.4 | 30.9 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
4.4 | 17.6 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
4.4 | 21.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
4.3 | 13.0 | GO:0021564 | vagus nerve development(GO:0021564) |
4.3 | 21.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
4.3 | 21.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
4.2 | 12.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
4.1 | 12.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
4.1 | 24.5 | GO:0035989 | tendon development(GO:0035989) |
4.1 | 8.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.0 | 12.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
3.9 | 11.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
3.9 | 11.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
3.9 | 11.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
3.9 | 11.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.9 | 7.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.9 | 11.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.8 | 7.7 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
3.8 | 11.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.8 | 84.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
3.8 | 7.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
3.8 | 30.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.8 | 7.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.8 | 11.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
3.7 | 18.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.7 | 14.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
3.7 | 3.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.7 | 7.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.6 | 14.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
3.6 | 10.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.6 | 3.6 | GO:0061743 | motor learning(GO:0061743) |
3.5 | 7.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
3.5 | 27.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
3.5 | 10.4 | GO:0030035 | microspike assembly(GO:0030035) |
3.5 | 3.5 | GO:0060594 | mammary gland specification(GO:0060594) |
3.5 | 6.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.5 | 17.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
3.4 | 10.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
3.4 | 13.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
3.4 | 27.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
3.4 | 10.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
3.4 | 10.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.3 | 16.7 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
3.3 | 6.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.3 | 6.7 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
3.3 | 13.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
3.3 | 26.5 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
3.3 | 13.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
3.3 | 13.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
3.2 | 19.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
3.2 | 29.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
3.2 | 3.2 | GO:0014028 | notochord formation(GO:0014028) |
3.2 | 6.5 | GO:0060166 | olfactory pit development(GO:0060166) |
3.2 | 6.4 | GO:0001757 | somite specification(GO:0001757) |
3.2 | 12.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
3.2 | 12.8 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.2 | 15.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.2 | 6.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
3.2 | 9.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
3.1 | 15.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
3.1 | 6.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
3.1 | 6.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
3.1 | 9.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.1 | 12.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.0 | 42.6 | GO:0060384 | innervation(GO:0060384) |
3.0 | 3.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
3.0 | 3.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.0 | 8.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
3.0 | 8.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
3.0 | 56.4 | GO:0001964 | startle response(GO:0001964) |
2.9 | 17.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
2.9 | 2.9 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.9 | 40.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.9 | 2.9 | GO:0033058 | directional locomotion(GO:0033058) |
2.9 | 43.4 | GO:0035640 | exploration behavior(GO:0035640) |
2.9 | 8.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.9 | 8.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
2.9 | 31.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
2.9 | 2.9 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.9 | 2.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.9 | 2.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.8 | 8.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
2.8 | 5.6 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
2.7 | 10.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.7 | 10.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
2.7 | 8.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.7 | 2.7 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
2.7 | 8.1 | GO:0097503 | sialylation(GO:0097503) |
2.7 | 10.8 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
2.7 | 2.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
2.6 | 2.6 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.6 | 7.9 | GO:0002930 | trabecular meshwork development(GO:0002930) |
2.6 | 7.9 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
2.6 | 7.9 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
2.6 | 2.6 | GO:0051795 | positive regulation of catagen(GO:0051795) |
2.6 | 7.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
2.6 | 7.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
2.6 | 5.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
2.6 | 12.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.5 | 2.5 | GO:0051794 | regulation of catagen(GO:0051794) |
2.5 | 7.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
2.5 | 5.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.5 | 127.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.5 | 9.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.5 | 9.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
2.5 | 7.4 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.5 | 4.9 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
2.4 | 12.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
2.4 | 24.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
2.4 | 4.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
2.4 | 4.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.4 | 7.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.4 | 14.4 | GO:0097264 | self proteolysis(GO:0097264) |
2.4 | 2.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.4 | 2.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
2.4 | 2.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
2.4 | 2.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
2.4 | 7.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
2.3 | 16.4 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
2.3 | 16.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
2.3 | 7.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.3 | 14.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.3 | 9.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.3 | 11.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.3 | 4.6 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
2.3 | 4.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.3 | 39.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.3 | 18.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
2.3 | 165.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
2.3 | 4.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.3 | 11.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
2.3 | 27.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
2.3 | 4.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.3 | 9.0 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
2.2 | 8.9 | GO:0022038 | corpus callosum development(GO:0022038) |
2.2 | 11.1 | GO:0060179 | male mating behavior(GO:0060179) |
2.2 | 2.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
2.2 | 6.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.2 | 8.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
2.2 | 2.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.2 | 2.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
2.2 | 11.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
2.2 | 6.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
2.2 | 11.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
2.2 | 13.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.2 | 26.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
2.2 | 6.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.1 | 4.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.1 | 19.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
2.1 | 8.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
2.1 | 4.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.1 | 4.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
2.1 | 14.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
2.1 | 2.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.1 | 8.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.1 | 16.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.0 | 12.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
2.0 | 8.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.0 | 4.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.0 | 10.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
2.0 | 2.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
2.0 | 2.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.0 | 7.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
2.0 | 5.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.0 | 2.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.0 | 3.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.0 | 5.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.9 | 3.9 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
1.9 | 7.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
1.9 | 17.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.9 | 3.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.9 | 7.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.9 | 7.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.9 | 9.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.9 | 5.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.9 | 16.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.9 | 5.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.9 | 16.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.9 | 1.9 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
1.8 | 5.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.8 | 1.8 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.8 | 3.6 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.8 | 1.8 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.8 | 3.6 | GO:0003032 | detection of oxygen(GO:0003032) |
1.8 | 7.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.8 | 5.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.8 | 18.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
1.8 | 21.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.8 | 1.8 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.8 | 5.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.8 | 12.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.8 | 8.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.8 | 3.6 | GO:0090135 | actin filament branching(GO:0090135) |
1.8 | 5.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.8 | 7.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.8 | 10.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.8 | 5.3 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
1.8 | 7.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
1.7 | 8.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.7 | 5.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.7 | 8.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.7 | 5.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.7 | 24.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.7 | 6.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.7 | 1.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.7 | 5.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
1.7 | 1.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.7 | 3.4 | GO:0061055 | myotome development(GO:0061055) |
1.7 | 8.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.7 | 10.1 | GO:0008038 | neuron recognition(GO:0008038) |
1.7 | 11.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.7 | 3.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.7 | 43.2 | GO:0019228 | neuronal action potential(GO:0019228) |
1.7 | 5.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.7 | 1.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.7 | 1.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.7 | 5.0 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.6 | 6.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.6 | 8.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.6 | 4.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.6 | 4.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.6 | 4.9 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.6 | 1.6 | GO:0021764 | amygdala development(GO:0021764) |
1.6 | 3.3 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
1.6 | 6.5 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
1.6 | 4.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.6 | 3.2 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
1.6 | 4.8 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
1.6 | 6.3 | GO:0048664 | neuron fate determination(GO:0048664) |
1.6 | 1.6 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.6 | 1.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.6 | 1.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.5 | 6.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
1.5 | 4.6 | GO:0051665 | membrane raft localization(GO:0051665) |
1.5 | 4.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.5 | 15.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.5 | 6.0 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
1.5 | 4.5 | GO:0030421 | defecation(GO:0030421) |
1.5 | 2.9 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.5 | 5.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.5 | 4.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.5 | 4.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.4 | 4.3 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.4 | 2.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.4 | 1.4 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.4 | 1.4 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.4 | 4.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.4 | 4.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.4 | 5.7 | GO:0044838 | cell quiescence(GO:0044838) |
1.4 | 18.5 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.4 | 2.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.4 | 14.2 | GO:0003334 | keratinocyte development(GO:0003334) |
1.4 | 4.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.4 | 5.6 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.4 | 2.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.4 | 2.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.4 | 4.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.4 | 7.0 | GO:0015808 | L-alanine transport(GO:0015808) |
1.4 | 9.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.4 | 1.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.4 | 5.6 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.4 | 5.6 | GO:0072017 | distal tubule development(GO:0072017) |
1.4 | 4.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.4 | 2.8 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
1.4 | 1.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.4 | 1.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.4 | 6.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.4 | 2.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.4 | 2.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.4 | 2.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.3 | 5.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.3 | 5.4 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
1.3 | 8.0 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.3 | 1.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.3 | 2.7 | GO:0090427 | activation of meiosis(GO:0090427) |
1.3 | 6.7 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.3 | 4.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.3 | 5.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.3 | 6.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.3 | 2.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.3 | 2.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.3 | 1.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.3 | 1.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.3 | 1.3 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
1.3 | 6.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.3 | 17.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.3 | 9.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.3 | 3.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.3 | 3.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.3 | 2.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.3 | 3.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
1.3 | 3.8 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
1.3 | 1.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.3 | 25.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
1.3 | 1.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.3 | 3.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.3 | 22.5 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
1.2 | 13.6 | GO:0008347 | glial cell migration(GO:0008347) |
1.2 | 6.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.2 | 3.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.2 | 3.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.2 | 2.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.2 | 1.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.2 | 6.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.2 | 4.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.2 | 1.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.2 | 2.4 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
1.2 | 4.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.2 | 1.2 | GO:1904995 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
1.2 | 7.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.2 | 5.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.2 | 5.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 3.5 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
1.2 | 1.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
1.2 | 5.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.2 | 2.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.2 | 1.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 10.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.1 | 3.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.1 | 3.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.1 | 2.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.1 | 5.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.1 | 2.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.1 | 2.2 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
1.1 | 4.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 6.6 | GO:0060068 | vagina development(GO:0060068) |
1.1 | 1.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.1 | 7.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.1 | 3.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.1 | 4.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.1 | 2.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.1 | 4.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.1 | 1.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.0 | 7.3 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
1.0 | 2.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.0 | 11.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.0 | 3.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.0 | 17.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.0 | 5.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.0 | 4.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 3.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.0 | 3.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.0 | 5.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.0 | 2.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.0 | 3.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.0 | 3.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 2.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.0 | 4.0 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.0 | 2.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 5.0 | GO:0015884 | folic acid transport(GO:0015884) |
1.0 | 2.0 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
1.0 | 4.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.0 | 6.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 3.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.0 | 1.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.0 | 2.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
1.0 | 7.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.0 | 3.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.0 | 2.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.0 | 2.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.0 | 2.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.0 | 3.8 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.0 | 1.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.0 | 1.9 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.9 | 15.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.9 | 1.9 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.9 | 1.9 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.9 | 5.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.9 | 3.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.9 | 5.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.9 | 30.5 | GO:0008542 | visual learning(GO:0008542) |
0.9 | 1.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.9 | 2.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 5.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.9 | 1.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.9 | 3.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.9 | 5.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 0.9 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.9 | 2.7 | GO:0048840 | otolith development(GO:0048840) |
0.9 | 2.7 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.9 | 2.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.9 | 0.9 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.9 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.9 | 3.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.9 | 3.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.9 | 12.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.9 | 1.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.9 | 2.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.9 | 0.9 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.9 | 0.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 7.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.9 | 2.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.9 | 3.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 1.8 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.9 | 3.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.9 | 1.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.9 | 1.7 | GO:0015755 | fructose transport(GO:0015755) |
0.8 | 0.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.8 | 0.8 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.8 | 1.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.8 | 4.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.8 | 3.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.8 | 0.8 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.8 | 1.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.8 | 0.8 | GO:0043366 | beta selection(GO:0043366) |
0.8 | 2.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.8 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 0.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.8 | 1.6 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.8 | 2.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.8 | 1.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.8 | 4.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.8 | 0.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.8 | 1.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.8 | 2.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.8 | 0.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.8 | 0.8 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.8 | 7.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.8 | 8.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.8 | 2.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.8 | 7.7 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.8 | 6.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.8 | 3.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.8 | 3.8 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.8 | 2.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 14.4 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.8 | 1.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.7 | 1.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.7 | 8.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.7 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 0.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.7 | 2.2 | GO:0043584 | nose development(GO:0043584) |
0.7 | 1.5 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 5.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.7 | 2.2 | GO:0061525 | hindgut development(GO:0061525) |
0.7 | 0.7 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.7 | 3.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.7 | 4.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.7 | 2.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.7 | 2.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.7 | 2.9 | GO:0007379 | segment specification(GO:0007379) |
0.7 | 20.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.7 | 3.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.7 | 1.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.7 | 4.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 1.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 1.4 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.7 | 1.4 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.7 | 0.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.7 | 1.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.7 | 2.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.7 | 2.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 2.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.7 | 2.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.7 | 1.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 2.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.7 | 2.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.7 | 1.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.7 | 1.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.7 | 13.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.7 | 1.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.7 | 7.2 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.7 | 0.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.6 | 1.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.6 | 0.6 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.6 | 1.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 0.6 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.6 | 3.2 | GO:0043586 | tongue development(GO:0043586) |
0.6 | 1.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.6 | 3.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.6 | 1.9 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 3.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.6 | 0.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.6 | 0.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.6 | 1.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 5.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.6 | 4.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.6 | 1.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.9 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.6 | 6.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.6 | 0.6 | GO:0060013 | righting reflex(GO:0060013) |
0.6 | 2.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 1.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 1.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 2.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 10.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.6 | 0.6 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.6 | 1.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 4.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.6 | 1.2 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.6 | 1.7 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 4.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.6 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.6 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 8.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 1.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 1.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 0.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.5 | 1.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.5 | 1.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 0.5 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.5 | 1.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.5 | 3.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.5 | 1.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.5 | 2.1 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.5 | 9.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 6.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 0.5 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.5 | 5.2 | GO:0022029 | telencephalon cell migration(GO:0022029) |
0.5 | 1.6 | GO:0031033 | myosin filament organization(GO:0031033) |
0.5 | 3.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 7.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.5 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 0.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 1.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.5 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.5 | 1.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 4.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 1.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.5 | 0.5 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.5 | 0.9 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.5 | 2.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 2.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.5 | 0.9 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.5 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.5 | 30.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.5 | 0.9 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 4.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 0.5 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.4 | 1.3 | GO:0060004 | reflex(GO:0060004) |
0.4 | 2.2 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.4 | 1.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 1.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 0.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 1.7 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 1.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 2.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 0.4 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.4 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 1.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 0.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 1.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 6.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 2.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.6 | GO:0043084 | penile erection(GO:0043084) |
0.4 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 5.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.4 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.4 | 2.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.4 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 2.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.4 | 1.1 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.4 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 1.9 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.4 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 0.4 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 5.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 18.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.4 | 1.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 0.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.4 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.5 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.4 | 0.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 0.7 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.4 | 1.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 1.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 1.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.3 | 1.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 2.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 2.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 1.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 3.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 1.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 2.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 2.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 8.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.3 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 2.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 1.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 8.9 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.3 | 25.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 5.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 0.9 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 2.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 1.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 1.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 0.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 2.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.3 | 1.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 2.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.9 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.8 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.8 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.7 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 2.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.2 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.7 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.2 | 1.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 1.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.2 | GO:0009584 | detection of visible light(GO:0009584) |
0.2 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.7 | GO:0060180 | female mating behavior(GO:0060180) |
0.2 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 3.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 6.1 | GO:0007612 | learning(GO:0007612) |
0.2 | 0.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.4 | GO:0014075 | response to amine(GO:0014075) |
0.2 | 1.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 1.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.6 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.8 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 0.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 4.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 5.8 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 1.1 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 1.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 1.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.4 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 1.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.9 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 2.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 1.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.4 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.1 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.3 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.1 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 3.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.1 | 0.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 55.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
7.2 | 64.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
6.7 | 53.9 | GO:0043083 | synaptic cleft(GO:0043083) |
6.5 | 19.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
6.2 | 18.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
6.2 | 18.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
6.0 | 30.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.5 | 22.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
5.5 | 16.5 | GO:0072534 | perineuronal net(GO:0072534) |
5.5 | 38.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
5.3 | 15.8 | GO:0097441 | basilar dendrite(GO:0097441) |
4.9 | 14.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
4.4 | 52.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
4.3 | 13.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
4.2 | 25.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.0 | 40.3 | GO:0043194 | axon initial segment(GO:0043194) |
4.0 | 36.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
4.0 | 24.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
3.8 | 11.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
3.7 | 62.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
3.6 | 10.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.4 | 10.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
3.3 | 9.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.1 | 84.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.1 | 34.2 | GO:0032433 | filopodium tip(GO:0032433) |
3.1 | 18.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.1 | 9.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
3.0 | 9.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.9 | 11.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.8 | 30.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.7 | 42.5 | GO:0005614 | interstitial matrix(GO:0005614) |
2.6 | 67.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.6 | 18.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.3 | 6.9 | GO:0048179 | activin receptor complex(GO:0048179) |
2.3 | 6.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.3 | 4.5 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.2 | 2.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.2 | 8.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.1 | 23.4 | GO:0001527 | microfibril(GO:0001527) |
2.1 | 12.5 | GO:0032584 | growth cone membrane(GO:0032584) |
2.0 | 16.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.0 | 8.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.0 | 119.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.0 | 49.7 | GO:0044295 | axonal growth cone(GO:0044295) |
2.0 | 5.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.9 | 3.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.9 | 7.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.8 | 11.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.8 | 56.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.8 | 30.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.8 | 8.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.8 | 10.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.8 | 7.0 | GO:0097433 | dense body(GO:0097433) |
1.7 | 5.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.7 | 5.2 | GO:0097427 | microtubule bundle(GO:0097427) |
1.7 | 5.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.6 | 233.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.6 | 19.1 | GO:0005605 | basal lamina(GO:0005605) |
1.6 | 4.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.6 | 12.6 | GO:0001520 | outer dense fiber(GO:0001520) |
1.5 | 13.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.5 | 18.2 | GO:0071564 | npBAF complex(GO:0071564) |
1.5 | 16.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.5 | 7.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.4 | 10.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.4 | 4.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.4 | 4.1 | GO:0000322 | storage vacuole(GO:0000322) |
1.4 | 12.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.3 | 4.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 13.3 | GO:0005916 | fascia adherens(GO:0005916) |
1.3 | 13.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.3 | 1.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.3 | 9.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.3 | 3.8 | GO:0043511 | inhibin complex(GO:0043511) |
1.3 | 3.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.3 | 15.0 | GO:0031045 | dense core granule(GO:0031045) |
1.2 | 2.4 | GO:1990357 | terminal web(GO:1990357) |
1.1 | 11.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.1 | 12.5 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 13.6 | GO:0031512 | motile primary cilium(GO:0031512) |
1.1 | 24.8 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
1.1 | 9.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.1 | 5.4 | GO:0071547 | piP-body(GO:0071547) |
1.1 | 118.4 | GO:0060076 | excitatory synapse(GO:0060076) |
1.1 | 3.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 3.1 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 8.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 4.1 | GO:0045180 | basal cortex(GO:0045180) |
1.0 | 29.1 | GO:0030175 | filopodium(GO:0030175) |
1.0 | 74.8 | GO:0030426 | growth cone(GO:0030426) |
1.0 | 5.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 3.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.9 | 3.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 5.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.9 | 28.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.9 | 4.3 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 3.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.8 | 4.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.8 | 23.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.8 | 20.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.8 | 75.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.8 | 3.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 6.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.8 | 10.1 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 6.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 3.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 1.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 37.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.7 | 2.2 | GO:0043205 | fibril(GO:0043205) |
0.7 | 2.1 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 2.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 2.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 2.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 40.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 7.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 2.0 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 1.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 4.5 | GO:0046930 | pore complex(GO:0046930) |
0.6 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 15.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.6 | 5.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 8.7 | GO:0000800 | lateral element(GO:0000800) |
0.6 | 3.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 7.0 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 120.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.5 | 3.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 2.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 2.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 2.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 3.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 3.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 1.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 3.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.4 | 3.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 3.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 2.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 1.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 1.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 14.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.3 | 1.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 1.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 0.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 7.8 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 13.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 2.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 2.6 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 1.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 1.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 2.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 1.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.0 | GO:0035363 | histone locus body(GO:0035363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.9 | 41.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
12.4 | 37.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
12.0 | 24.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
9.5 | 28.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
8.6 | 43.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
8.4 | 25.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
7.5 | 22.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
7.0 | 34.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.7 | 6.7 | GO:0055100 | adiponectin binding(GO:0055100) |
6.6 | 26.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
6.6 | 19.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
6.5 | 25.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
6.3 | 31.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.8 | 28.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
5.7 | 17.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
5.6 | 33.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
5.6 | 39.1 | GO:0003680 | AT DNA binding(GO:0003680) |
5.5 | 16.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.0 | 24.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.0 | 9.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.8 | 28.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.6 | 4.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
4.4 | 17.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
4.2 | 16.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.0 | 75.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
4.0 | 12.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.9 | 19.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.9 | 11.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.9 | 11.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.9 | 15.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.9 | 11.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.8 | 23.0 | GO:0048495 | Roundabout binding(GO:0048495) |
3.8 | 15.2 | GO:0071253 | connexin binding(GO:0071253) |
3.8 | 18.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
3.7 | 7.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
3.5 | 38.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
3.5 | 10.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.5 | 31.4 | GO:0038191 | neuropilin binding(GO:0038191) |
3.5 | 13.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.4 | 6.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.4 | 10.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
3.4 | 13.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
3.4 | 43.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
3.2 | 9.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
3.2 | 6.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
3.1 | 3.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
3.1 | 12.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
3.0 | 21.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.9 | 14.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.9 | 11.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.9 | 74.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
2.8 | 2.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.8 | 25.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.8 | 22.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.8 | 19.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.8 | 2.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
2.8 | 2.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.7 | 2.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.7 | 5.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.7 | 5.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.7 | 27.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
2.7 | 10.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.7 | 13.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.7 | 5.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.7 | 8.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.6 | 10.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
2.6 | 7.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.6 | 7.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.6 | 12.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.5 | 10.1 | GO:0097001 | ceramide binding(GO:0097001) |
2.5 | 7.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.4 | 12.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.3 | 65.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.3 | 9.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
2.3 | 9.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.3 | 30.1 | GO:0015026 | coreceptor activity(GO:0015026) |
2.3 | 6.9 | GO:0016015 | morphogen activity(GO:0016015) |
2.3 | 6.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
2.3 | 9.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.3 | 6.8 | GO:0035939 | microsatellite binding(GO:0035939) |
2.2 | 11.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.2 | 26.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
2.2 | 91.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
2.2 | 17.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.2 | 30.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
2.2 | 6.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.1 | 12.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
2.1 | 6.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.1 | 8.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.1 | 2.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.0 | 8.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.0 | 7.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.9 | 5.8 | GO:0051373 | FATZ binding(GO:0051373) |
1.9 | 48.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.9 | 57.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.9 | 28.1 | GO:0031402 | sodium ion binding(GO:0031402) |
1.9 | 5.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.9 | 7.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.8 | 5.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.8 | 3.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.8 | 7.1 | GO:0070052 | collagen V binding(GO:0070052) |
1.8 | 21.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.8 | 14.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.8 | 7.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.7 | 3.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.7 | 5.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.7 | 6.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.7 | 5.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.7 | 10.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.7 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.7 | 33.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.6 | 3.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.6 | 8.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.6 | 38.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.6 | 49.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.6 | 17.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.6 | 4.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.6 | 20.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.6 | 3.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.6 | 18.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.6 | 15.5 | GO:0051378 | serotonin binding(GO:0051378) |
1.5 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.5 | 9.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.5 | 9.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 11.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.5 | 2.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.5 | 5.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
1.5 | 4.4 | GO:0051425 | PTB domain binding(GO:0051425) |
1.5 | 8.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.5 | 13.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.4 | 5.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.4 | 4.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.4 | 14.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.4 | 7.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.4 | 15.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 4.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.4 | 12.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.4 | 4.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.4 | 35.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.4 | 27.0 | GO:0003785 | actin monomer binding(GO:0003785) |
1.3 | 36.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.3 | 14.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.3 | 6.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.3 | 26.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.3 | 5.1 | GO:0034584 | piRNA binding(GO:0034584) |
1.3 | 3.8 | GO:0034711 | inhibin binding(GO:0034711) |
1.3 | 7.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.3 | 6.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 3.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.2 | 6.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.2 | 2.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.2 | 5.9 | GO:0031432 | titin binding(GO:0031432) |
1.2 | 2.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.2 | 3.5 | GO:0004096 | catalase activity(GO:0004096) |
1.2 | 4.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.1 | 3.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.1 | 15.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 23.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.1 | 7.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.1 | 19.9 | GO:0031489 | myosin V binding(GO:0031489) |
1.1 | 5.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 4.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.1 | 3.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.1 | 5.4 | GO:1990254 | keratin filament binding(GO:1990254) |
1.1 | 43.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.1 | 13.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.0 | 5.2 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.0 | 4.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.0 | 2.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.0 | 14.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
1.0 | 2.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.0 | 7.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.0 | 4.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.0 | 3.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 4.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.0 | 4.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.0 | 6.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.9 | 8.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.9 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 10.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 51.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.9 | 5.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.9 | 2.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.9 | 5.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.9 | 3.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.9 | 3.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.9 | 31.0 | GO:0017022 | myosin binding(GO:0017022) |
0.9 | 2.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.9 | 5.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.9 | 4.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 3.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.9 | 2.6 | GO:0048185 | activin binding(GO:0048185) |
0.9 | 7.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.9 | 5.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.9 | 0.9 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.8 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.8 | 2.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 2.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 6.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.8 | 2.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 5.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.8 | 2.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.8 | 1.6 | GO:0070905 | serine binding(GO:0070905) |
0.8 | 2.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 2.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.8 | 7.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 1.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.8 | 11.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.8 | 4.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.8 | 13.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 13.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 4.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.8 | 9.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 12.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.8 | 96.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.8 | 7.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.8 | 3.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 17.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.8 | 3.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.8 | 1.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 8.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.8 | 2.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 9.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.8 | 6.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 2.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 2.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 0.7 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.7 | 4.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 2.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.7 | 7.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.7 | 2.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 5.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.7 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.7 | 4.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.7 | 18.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 25.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.7 | 3.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 0.7 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.7 | 3.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.7 | 6.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 8.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 1.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 1.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 2.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 1.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 7.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.6 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 4.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 2.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 13.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 1.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.6 | 6.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.6 | 1.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 1.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.6 | 2.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 4.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 2.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 2.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.6 | 5.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 1.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.6 | 5.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 2.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 28.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.5 | 1.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 2.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 2.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 19.8 | GO:0004394 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.5 | 3.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 13.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 3.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.5 | 3.5 | GO:0005267 | potassium channel activity(GO:0005267) |
0.5 | 2.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 1.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 6.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 2.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 6.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.5 | 13.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.5 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 2.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 7.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 2.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 1.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 0.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 2.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 2.3 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 1.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 5.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 0.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.4 | 6.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 13.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 3.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 0.8 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 2.8 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 3.8 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.4 | 5.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 34.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 4.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 2.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 2.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 5.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) acetylcholine receptor activity(GO:0015464) |
0.3 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 2.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 6.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 0.9 | GO:0034927 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 0.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 2.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 5.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 3.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 2.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 2.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 2.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 2.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 7.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 2.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.3 | GO:0099528 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 3.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 2.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 3.7 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 1.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 4.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 2.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 19.8 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.3 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
3.6 | 67.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
2.8 | 89.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.5 | 2.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.1 | 39.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
2.1 | 22.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.0 | 25.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.9 | 48.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.9 | 7.7 | PID REELIN PATHWAY | Reelin signaling pathway |
1.9 | 7.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.8 | 60.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.8 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.7 | 58.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.7 | 35.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.7 | 18.3 | PID ALK2 PATHWAY | ALK2 signaling events |
1.6 | 70.6 | NABA COLLAGENS | Genes encoding collagen proteins |
1.5 | 7.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.5 | 1.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.4 | 2.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.4 | 17.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.4 | 25.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.4 | 25.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.4 | 34.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.3 | 14.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.2 | 53.7 | PID SHP2 PATHWAY | SHP2 signaling |
1.2 | 14.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.2 | 4.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.1 | 181.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.1 | 14.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.1 | 2.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.1 | 2.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.9 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 10.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 10.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 54.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.8 | 4.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 12.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 6.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 24.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 12.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 2.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 12.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 2.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.6 | 139.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 2.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 6.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 44.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 1.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 10.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 4.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 5.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 43.4 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 5.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
4.5 | 63.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
4.1 | 144.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
3.9 | 7.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
3.7 | 85.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.7 | 44.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.6 | 40.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.4 | 51.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.0 | 57.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.9 | 11.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.8 | 30.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.7 | 32.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
2.7 | 115.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.7 | 5.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.5 | 33.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
2.5 | 61.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.3 | 27.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
2.2 | 31.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.2 | 17.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.1 | 21.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.9 | 99.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.8 | 7.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.8 | 26.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.8 | 7.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.7 | 33.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.7 | 15.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.7 | 28.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.7 | 37.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.7 | 6.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.5 | 37.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.5 | 13.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.4 | 14.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.3 | 25.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.3 | 19.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.3 | 11.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.2 | 18.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.2 | 14.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.1 | 13.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.0 | 18.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.0 | 7.7 | REACTOME OPSINS | Genes involved in Opsins |
0.9 | 10.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.9 | 11.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 9.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.8 | 9.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 0.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.8 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 2.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.8 | 8.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 4.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 5.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 5.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 23.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 4.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.6 | 3.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.6 | 15.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 2.9 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.6 | 9.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 9.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.5 | 4.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 8.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.4 | 3.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 21.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 4.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 8.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 0.3 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 0.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 6.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 3.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 4.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 3.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |